2015
DOI: 10.1016/j.bmc.2015.02.014
|View full text |Cite
|
Sign up to set email alerts
|

Pheophorbide-a conjugates with cancer-targeting moieties for targeted photodynamic cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
23
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(25 citation statements)
references
References 25 publications
2
23
0
Order By: Relevance
“…20%. Our results are in line with what reported earlier in literature for different constructs[91][92][93][94][95], indicating that synergistic chemo-photodynamic therapy mediated by diatom microalgae is a strategy worthwhile pursuing in colon-focused drug delivery. It is well known that undesirable side effects of most chemotherapeutics like cisplatin are dose dependent[96], thus this approach can reduce the need of chemotherapeutics concentration for equal effectiveness hence leading to diminished undesirable side effects for the patient.…”
supporting
confidence: 92%
“…20%. Our results are in line with what reported earlier in literature for different constructs[91][92][93][94][95], indicating that synergistic chemo-photodynamic therapy mediated by diatom microalgae is a strategy worthwhile pursuing in colon-focused drug delivery. It is well known that undesirable side effects of most chemotherapeutics like cisplatin are dose dependent[96], thus this approach can reduce the need of chemotherapeutics concentration for equal effectiveness hence leading to diminished undesirable side effects for the patient.…”
supporting
confidence: 92%
“…The intention is to rely on the ability of the targeting vehicle to control localization so that the PS can be chosen based on its photochemical properties rather than on its tumour targeting properties, which are often unimpressive. These targeting vehicles include monoclonal antibodies [74], antibody fragments [75], peptides [76], proteins such as transferrin [77], epidermal growth factor [77] and insulin [78], LDL [79], various carbohydrates [80], somatostatin [81], folic acid [82] and many others. Table 4 lists some of these targeting ligand–PS conjugates.…”
Section: Targeted Pdtmentioning
confidence: 99%
“…a). Targeting moieties used for this purpose include folic acid, peptides, antibodies and carbohydrates (Table ), and can be either conjugated to a nanoparticle or directly to a PS.…”
Section: Targeting the Tumor Microenvironment With Photochemistrymentioning
confidence: 99%
“…8a). Targeting moieties used for this purpose include folic acid, peptides, antibodies and carbohydrates (325)(326)(327)(328)(329)(330)(331)(332)(333)(334)(335)(336)(337)(338) (Table 3), and can be either conjugated to a nanoparticle or directly to a PS. Most PDT treatments that incorporate such targeting moieties are designed to directly target cancer cells.…”
Section: Targeted Deliverymentioning
confidence: 99%